e-ISSN 2147-2475
Cilt : 12 Say : 1 Yl : 2023

Hzl Arama




COVID-19a Bal Diffz Alveoler Hemoraji: Olgu Sunumu [Respir Case Rep]
Respir Case Rep. 2022; 11(3): 156-159 | DOI: 10.5505/respircase.2022.66587

COVID-19a Bal Diffz Alveoler Hemoraji: Olgu Sunumu

Glbahar Darlmaz Yce1, Dorina Esendal1, Koray Hekimolu2, Merih Tepeolu3, Merref ule Akay1
1Bakent niversitesi Gs Hastalklar Anabilim Dal, Ankara
2Bakent niversitesi, Radyoloji Anabilim Dal, Ankara
3Bakent niversitesi, Tbbi Patoloji Anabilim Dal, Ankara

Diffz alveoler hemoraji, ksrk, hemoptizi, yaygn pulmoner infiltratlar, anemi ve hipoksemik solunum sknts ile karakterize bir sendromdur. Etyolojisinde akcier enfeksiyonlar da rol oynamaktadr. Enfeksiyon riski nedeniyle COVID-19 hastalarnda bronkoskopi kullanmnn kstlanmas, diffz alveoler hemorajinin COVID-19da yeterince tannamamasna neden olmaktadr. Burada SARS-CoV-2 balamnda laboratuvar, radyolojik ve bronkoskopik olarak diffz alveoler hemoraji kant olan 35 yandaki hastada SARS-CoV-2 iin nasofarengeal srnt polymerase chain reaction (PCR) testi negatif saptanm, COVID-19 tans bron lavaj ile konulabilmitir. Yksek enfeksiyon riski nedeniyle pandemi dneminde bronkoskopi kullanmnn kstlanmas, SARS-CoV-2 PCR testi negatif immnsupresif hastalarda COVID-19 tansnn yanllkla dlanmasna veya SARS-CoV-2 PCR pozitif hastalarda diffz alveoler hemoraji ve sekonder enfeksiyon gibi durumlarn yeterince tannamamasna neden olmaktadr.

Anahtar Kelimeler: COVID-19, Diffz alveolar hemoraji, buzlu cam opasiteler

COVID-19-Associated Diffuse Alveolar Hemorrhage: A Case Report

Glbahar Darlmaz Yce1, Dorina Esendal1, Koray Hekimolu2, Merih Tepeolu3, Merref ule Akay1
1Department of Chest Diseases, Bakent University, Ankara, Trkiye
2Department of Radiology, Bakent University, Ankara, Trkiye
3Department of Medical Pathology, Baskent University, Ankara, Trkiye

Diffuse alveolar hemorrhage is a syndrome characterized by cough, hemoptysis, diffuse pulmonary infiltrates, anemia, and hypoxemic respiratory distress, and lung infections also play a role in its etiology. The restricted use of bronchoscopy in COVID-19 patients due to the risk of infection has led to the poor recognition of diffuse alveolar hemorrhage in COVID-19. We present here the case of a 35-year-old patient with laboratory, radiological and bronchoscopic evidence of diffuse alveolar hemorrhage who was diagnosed with COVID-19 by bronchial lavage. The restrictions on the use of bronchoscopy during the pandemic due to the high risk of infection has led diagnoses of COVID-19 to be mistakenly excluded in immunosuppressive patients with a negative SARS-CoV-2 polymerase chain reaction test, and the under-recognition of conditions such as diffuse alveolar hemorrhage and secondary infection in patients with a positive SARS-CoV-2 PCR.

Keywords: COVID-19, Diffuse alveolar hemorrhage, ground-glass opacities

Olgunun Grnt Kesitleri




Glbahar Darlmaz Yce, Dorina Esendal, Koray Hekimolu, Merih Tepeolu, Merref ule Akay. COVID-19-Associated Diffuse Alveolar Hemorrhage: A Case Report. Respir Case Rep. 2022; 11(3): 156-159

Sorumlu Yazar: Glbahar Darlmaz Yce, Trkiye
Makale Dili: ngilizce
LookUs & Online Makale